Anti-Coagulation-Associated Intracerebral Hemorrhage

For individuals with anti-coagulation-associated intracerebral hemorrhage, a door-to-treatment time of 60 minutes or fewer was associated with decreased mortality and discharge to hospice care, according to research from JAMA Neurology.